跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AF-1
首页
药物
AF-1
AF-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
2'-substituted 1,1'-biphenyl-2-carboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them
US 7514582 B2
申请人: SANOFI AVENTIS DEUTSCHLAND
优先权: 2000
US
7 件公开
TREATMENT OF ATRIAL FIBRILLATION
CN 104324024 A
申请人: HUYA INTERNAT LLC
优先权: 2009
CN
US
5 件公开
PROCESS FOR PRODUCING EGG YOLK WITH HIGH CONTENT OF AF-16
EP 3319618 A1
申请人: LANTMAENNEN AS FAKTOR AB
优先权: 2015
CN
EP
US
WO
4 件公开
CRYSTAL FORMS OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDE
EP 4387968 B1
申请人: BRISTOL MYERS SQUIBB CO
优先权: 2021
CN
EP
US
WO
4 件公开
Anthranilamides and methods of their use
US 7235690 B2
申请人: SANOFI AVENTIS DEUTSCHLAND
优先权: 2001
US
4 件公开
Novel fluorinated compound and fluoropolymer
US 2006194936 A1
申请人: ASAHI GLASS CO LTD
优先权: 2003
CN
EP
US
3 件公开
Arylated furan- and thiophenecarboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them
US 6982279 B2
申请人: AVENTIS PHARM DEUTSCHLAND GMBH
优先权: 2000
CN
US
3 件公开
USE OF ANTISECRETORY FACTORS (AF) FOR OPTIMIZING CELLULAR UPTAKE
EP 3769778 A1
申请人: LANTMAENNEN MEDICAL AB
优先权: 2009
CN
EP
3 件公开
Substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them
US 9127001 B2
申请人: BIALY LAURENT
优先权: 2011
CN
US
3 件公开
Processes for the preparation of fluorinated acyl fluorides and fluorinated vinyl ethers
US 6919480 B2
申请人: ASAHI GLASS CO LTD
优先权: 2000
US
3 件公开
第 1 / 5 页
上一页
下一页
药物
反馈